Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monotherapy vs Dual Therapy for Initial Treatment of Hypertension
2008-007749-29Phase 4Completed
- Sponsor
- R&D Department,
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of losartan, losartan + hydrochlorothiazide, hydrochlorothiazide, amlodipine and doxazosin in hypertension (HTN) and resistant hypertension (RH) (2 arms), sponsored by R&D Department,. Primary endpoint: Change in mean home systolic blood pressure. Started Jul 2010; status: completed.
02
Drugs
losartanlosartan + hydrochlorothiazidehydrochlorothiazideamlodipinedoxazosin
03
Conditions
hypertension (HTN)resistant hypertension (RH)
Beyond the preview
Go deeper on 2008-007749-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007749-29.